Trademark: 97849603
Word
ASTER INSIGHTS
Status Date
Tuesday, June 18, 2024
Filing Date
Tuesday, March 21, 2023
Published for Opposition
Tuesday, April 23, 2024
44 Providing an electronic database for the collection and storage of clinical and molecular data derived from a patient, namely, an electronic database featuring medical information in the field of human clinical and molecular data analysis for aiding medical diagnostics, discovery and development and prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases; Health care services, namely, providing a database in the field of cancer and other disease medical information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Providing a database in the field of human clinical and molecular data accumulation and analysis for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness, namely, providing medical information data regarding tumor-specific molecular signatures, providing objective medical information data on the effectiveness of a drug and/or diagnostic test, and providing evidence-based treatment protocols by effectively comparing standard treatment therapies with clinical outcomes; collection and analysis of data services in the field of human clinical and molecular data for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases, namely, medical services in the nature of matching particular patients to a particular drug, treatment, therapy or clinical trial by the specific molecular signature of the patient; providing an Internet-accessible website portal featuring medical records for use by physicians, patients and researchers for the storage and accessibility of electronic medical information data in the field of human clinical and molecular data and analysis for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness; providing consulting services relating thereto for the aforementioned services.
42 Providing an electronic database for the collection and storage of clinical and molecular data derived from a patient, namely, an electronic database featuring medical and scientific research information in the field of human clinical and molecular data analysis for aiding medical diagnostics, discovery and development and prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases; medical and scientific research data analysis and bioinformatics consulting services relating thereto, namely, computer software consulting, providing online non-downloadable computer software platforms for analyzing medical and scientific research data, and scientific research data analytics consulting in connection with an electronic database for the collection and storage of medical and scientific research information in the fields of clinical and molecular data accumulated for aiding medical diagnostic, discovery and development and prognostics and evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases; providing an Internet-accessible website portal featuring medical records for use by physicians, patients and researchers for the storage and accessibility of electronic medical research data in the field of human clinical and molecular data and analysis for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness; providing consulting services relating thereto for the aforementioned services
Mar 24, 2023
New Application Entered
Apr 12, 2023
New Application Office Supplied Data Entered
Dec 15, 2023
Assigned To Examiner
Feb 19, 2024
Teas Response To Office Action Received
Dec 18, 2023
Non-Final Action Written
Dec 18, 2023
Non-Final Action E-Mailed
Dec 18, 2023
Notification Of Non-Final Action E-Mailed
Feb 19, 2024
Correspondence Received In Law Office
Feb 19, 2024
Teas/Email Correspondence Entered
Feb 28, 2024
Non-Final Action Written
Feb 28, 2024
Non-Final Action E-Mailed
Feb 28, 2024
Notification Of Non-Final Action E-Mailed
Mar 21, 2024
Examiners Amendment -Written
Mar 21, 2024
Examiners Amendment E-Mailed
Mar 21, 2024
Notification Of Examiners Amendment E-Mailed
Mar 21, 2024
Examiner's Amendment Entered
Mar 21, 2024
Approved For Pub - Principal Register
Apr 3, 2024
Notification Of Notice Of Publication E-Mailed
Apr 3, 2024
Notification Of Notice Of Publication E-Mailed
Apr 23, 2024
Published For Opposition
Apr 23, 2024
Official Gazette Publication Confirmation E-Mailed
Jun 18, 2024
Noa E-Mailed - Sou Required From Applicant
Apr 3, 2024
Notification Of Notice Of Publication E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
